Jieming Li
Impact in
-
- Gallbladder and Bile Duct Disorders
- Biliary and Gastrointestinal Fistulas
-
- Ovarian function and disorders
Papers in
-
- Gallbladder and Bile Duct Disorders 3
- Co-authors
- Guozhong Wu (4 shared papers)Zhitao Dong (4 shared papers)Kunlun Luo (4 shared papers)Weijie Zhang (2 shared papers)Xiao‐Dong Mo (1 shared paper)Guifang Xu (1 shared paper)Xin-Zhou Li (1 shared paper)Hongbo Cheng (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry (2 papers)Medicine (2 papers)Journal of Surgical Research (2 papers)International Journal of Molecular Medicine (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Jieming Li
19 papers receiving 416 citations
Peers
Comparison fields: 5 of 65
- Pulmonary and Respiratory Medicine 214
- Reproductive Medicine 24
- Oncology 60
- Toxicology 8
- Statistical and Nonlinear Physics 31
Countries citing papers authored by Jieming Li
This map shows the geographic impact of Jieming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieming Li more than expected).
Fields of papers citing papers by Jieming Li
This network shows the impact of papers produced by Jieming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieming Li. The network helps show where Jieming Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Jieming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 68 | |
| 2 | 2009 | 64 | |
| 3 | 2008 | 47 | |
| 4 | 2015 | 40 | |
| 5 | 1997 | 37 | |
| 6 | 2017 | 28 | |
| 7 | 2020 | 22 | |
| 8 | 2016 | 21 | |
| 9 | 2015 | 18 | |
| 10 | 2023 | 15 | |
| 11 | 2018 | 15 | |
| 12 | 2017 | 13 | |
| 13 | Integrin-associated CD151 is a suppressor of prostate cancer progression. | 2020 | 10 |
| 14 | 2019 | 9 | |
| 15 | 2025 | 6 | |
| 16 | 2019 | 6 | |
| 17 | [Survey of health status and healthcare service demand of perimenopausal women in Guangdong]. | 2004 | 6 |
| 18 | 2000 | 4 | |
| 19 | 2023 | 1 |
About Jieming Li
Jieming Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health, having authored 19 papers that have together received 430 indexed citations. Recurring topics across this work include Gallbladder and Bile Duct Disorders (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Cell Adhesion Molecules Research (2 papers), Lipid metabolism and disorders (2 papers), Ovarian function and disorders (1 paper), Liver physiology and pathology (1 paper), Quantum Chromodynamics and Particle Interactions (1 paper) and Liver Disease Diagnosis and Treatment (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (214 citations), Reproductive Medicine (24 citations), Oncology (60 citations), Toxicology (8 citations) and Statistical and Nonlinear Physics (31 citations). Jieming Li has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Guozhong Wu, Zhitao Dong, Kunlun Luo, Weijie Zhang, Xiao‐Dong Mo, Guifang Xu, Xin-Zhou Li, Hongbo Cheng, Hai Qian and Chen Liao. Their work appears in journals such as Bioorganic & Medicinal Chemistry, Medicine, Journal of Surgical Research, International Journal of Molecular Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.